A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)

Clinical trial NCT00964990 · TERMINATED

Trial details

NCT number: NCT00964990
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain Neuralgia, Postherpetic Neuralgia Mononeuropathies

Start date: 2009-09-01
Primary completion: 2011-07-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.